Cytokinetics, Incorporated (CYTK)
NASDAQ: CYTK · IEX Real-Time Price · USD
70.11
-1.30 (-1.82%)
At close: Mar 28, 2024, 4:00 PM
70.05
-0.06 (-0.09%)
After-hours: Mar 28, 2024, 4:47 PM EDT

Cytokinetics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2001
Revenue
7.5394.5970.4355.8326.8731.513.37106.4128.6646.94
Upgrade
Revenue Growth (YoY)
-92.04%34.30%26.15%107.79%-14.71%135.64%-87.44%271.30%-38.95%53.16%
Upgrade
Gross Profit
7.5394.5970.4355.8326.8731.513.37106.4128.6646.94
Upgrade
Selling, General & Admin
173.61177.9896.852.8239.6131.2836.4727.8219.6717.27
Upgrade
Research & Development
330.12240.81159.9496.9586.1389.1490.359.946.444.43
Upgrade
Operating Expenses
503.74418.79256.74149.77125.74120.42126.7687.7266.0761.69
Upgrade
Operating Income
-496.21-324.2-186.31-93.94-98.87-88.92-113.418.69-37.41-14.75
Upgrade
Interest Expense / Income
28.3119.4116.4415.966.623.83.022.70.270
Upgrade
Other Expense / Income
1.7345.3412.5617.3816.213.5811.38-0.46-0.17-0.11
Upgrade
Pretax Income
-526.24-388.96-215.31-127.29-121.69-106.29-127.7916.45-37.5-14.65
Upgrade
Net Income
-526.24-388.96-215.31-127.29-121.69-106.29-127.7916.45-37.5-14.65
Upgrade
Shares Outstanding (Basic)
97907765585449403936
Upgrade
Shares Outstanding (Diluted)
97907765585449433936
Upgrade
Shares Change
7.46%16.83%19.16%12.07%5.80%10.15%16.08%9.65%8.70%30.92%
Upgrade
EPS (Basic)
-5.45-4.33-2.80-1.97-2.11-1.95-2.590.41-0.97-0.41
Upgrade
EPS (Diluted)
-5.45-4.33-2.80-1.97-2.11-1.95-2.590.39-0.97-0.41
Upgrade
Free Cash Flow
-415.75-310.85-191.39-2.11-93.53-102.09-104.6435.424.32-45.95
Upgrade
Free Cash Flow Per Share
-4.31-3.46-2.49-0.03-1.62-1.88-2.120.890.11-1.29
Upgrade
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%
Upgrade
Operating Margin
-6589.71%-342.75%-264.54%-168.27%-367.97%-282.26%-848.26%17.56%-130.53%-31.43%
Upgrade
Profit Margin
-6988.63%-411.21%-305.72%-228.00%-452.93%-337.41%-955.94%15.46%-130.86%-31.20%
Upgrade
Free Cash Flow Margin
-5521.24%-328.64%-271.76%-3.78%-348.09%-324.08%-782.73%33.29%15.08%-97.88%
Upgrade
EBITDA
-486.05-363.73-196.6-109.5-113.78-101.25-122.8519.89-36.64-14.16
Upgrade
EBITDA Margin
-6454.79%-384.54%-279.15%-196.13%-423.46%-321.43%-919.02%18.69%-127.87%-30.16%
Upgrade
Depreciation & Amortization
11.895.812.281.831.291.241.920.740.590.49
Upgrade
EBIT
-497.94-369.54-198.87-111.33-115.07-102.49-124.7719.15-37.23-14.65
Upgrade
EBIT Margin
-6612.72%-390.68%-282.38%-199.41%-428.28%-325.36%-933.38%18.00%-129.92%-31.20%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).